D. Roberts and S. Dalziel, Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth, Cochrane Database Syst Rev, vol.3, p.4454, 2006.

O. Itani, S. Auerbach, R. Husted, K. Volk, and S. Ageloff, expression, American Journal of Physiology - Lung Cellular and Molecular Physiology, vol.282, issue.4, pp.631-641, 2002.
DOI : 10.1152/ajplung.00085.2001

E. Hummler, P. Barker, J. Gatzy, F. Beermann, and C. Verdumo, Early death due to defective neonatal lung liquid clearance in ??ENaC-deficient mice, Nature Genetics, vol.13, issue.3, pp.325-328, 1996.
DOI : 10.1016/0925-4773(93)90098-I

D. Sloboda, J. Newnham, and J. Challis, Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary-adrenal function of the ovine fetus at term, Journal of Endocrinology, vol.165, issue.1, pp.79-91, 2000.
DOI : 10.1677/joe.0.1650079

R. Benediktsson, R. Lindsay, J. Noble, J. Seckl, and C. Edwards, Glucocorticoid exposure in utero: new model for adult hypertension, The Lancet, vol.341, issue.8841, pp.339-341, 1993.
DOI : 10.1016/0140-6736(93)90138-7

M. Dodic, A. Peers, J. Coghlan, and M. Wintour, Can Excess Glucocorticoid, in Utero, Predispose to Cardiovascular and Metabolic Disease in Middle Age?, Trends in Endocrinology & Metabolism, vol.10, issue.3, pp.86-91, 1999.
DOI : 10.1016/S1043-2760(98)00125-8

S. Huh, R. Andrew, J. Rich-edwards, K. Kleinman, and J. Seckl, Association between umbilical cord glucocorticoids and blood pressure at age 3 years, BMC Medicine, vol.29, issue.1, p.25, 2008.
DOI : 10.1016/j.placenta.2007.10.010

M. Nyirenda, R. Lindsay, C. Kenyon, A. Burchell, and J. Seckl, Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring., Journal of Clinical Investigation, vol.101, issue.10, pp.2174-2181, 1998.
DOI : 10.1172/JCI1567

L. Welberg, J. Seckl, and M. Holmes, Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour, Neuroscience, vol.104, issue.1, pp.71-79, 2001.
DOI : 10.1016/S0306-4522(01)00065-3

C. Bertram and M. Hanson, Prenatal programming of postnatal endocrine responses by glucocorticoids, Reproduction, vol.124, issue.4, pp.459-467, 2002.
DOI : 10.1530/rep.0.1240459

C. Wyrwoll, P. Mark, and B. Waddell, Developmental Programming of Renal Glucocorticoid Sensitivity and the Renin-Angiotensin System, Hypertension, vol.50, issue.3, pp.579-584, 2007.
DOI : 10.1161/HYPERTENSIONAHA.107.091603

S. Diederich, E. Eigendorff, P. Burkhardt, M. Quinkler, and C. Bumke-vogt, 11??-Hydroxysteroid Dehydrogenase Types 1 and 2: An Important Pharmacokinetic Determinant for the Activity of Synthetic Mineralo- and Glucocorticoids, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.12, pp.5695-5701, 2002.
DOI : 10.1210/jc.2002-020970

M. Shams, M. Kilby, D. Somerset, A. Howie, and A. Gupta, 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction, Human Reproduction, vol.13, issue.4, pp.799-804, 1998.
DOI : 10.1093/humrep/13.4.799

E. Kajantie, L. Dunkel, U. Turpeinen, U. Stenman, and P. Wood, Placental 11??-Hydroxysteroid Dehydrogenase-2 and Fetal Cortisol/Cortisone Shuttle in Small Preterm Infants, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.1, pp.493-500, 2003.
DOI : 10.1210/jc.2002-021378

E. Schoof, M. Girstl, W. Frobenius, M. Kirschbaum, and H. Dorr, Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia, J Clin Endocrinol Metab, vol.86, pp.1313-1317, 2001.

C. Wyrwoll, J. Seckl, and M. Holmes, Altered Placental Function of 11??-Hydroxysteroid Dehydrogenase 2 Knockout Mice, Endocrinology, vol.150, issue.3, pp.1287-1293, 2009.
DOI : 10.1210/en.2008-1100

G. Hirasawa, H. Sasano, T. Suzuki, J. Takeyama, and Y. Muramatu, 11Beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in human fetal development, J Clin Endocrinol Metab, vol.84, pp.1453-1458, 1999.

N. Draper and P. Stewart, 11??-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action, Journal of Endocrinology, vol.186, issue.2, pp.251-271, 2005.
DOI : 10.1677/joe.1.06019

S. Viengchareun, L. Menuet, D. Martinerie, L. Munier, M. et al., The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology, Nuclear Receptor Signaling, vol.4, p.12, 2007.
DOI : 10.1621/nrs.05012
URL : https://hal.archives-ouvertes.fr/inserm-00193515

N. Farman and M. Rafestin-oblin, Multiple aspects of mineralocorticoid selectivity, Am J Physiol Renal Physiol, vol.280, pp.181-192, 2001.

S. Ulick, L. Levine, P. Gunczler, G. Zanconato, and L. Ramirez, A Syndrome of Apparent Mineralocorticoid Excess Associated with Defects in the Peripheral Metabolism of Cortisol*, The Journal of Clinical Endocrinology & Metabolism, vol.49, issue.5, pp.757-764, 1979.
DOI : 10.1210/jcem-49-5-757

T. Mune and P. White, Apparent Mineralocorticoid Excess : Genotype Is Correlated With Biochemical Phenotype, Hypertension, vol.27, issue.6, pp.1193-1199, 1996.
DOI : 10.1161/01.HYP.27.6.1193

P. Stewart, J. Corrie, C. Shackleton, and C. Edwards, Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle., Journal of Clinical Investigation, vol.82, issue.1, pp.340-349, 1988.
DOI : 10.1172/JCI113592

R. Brown, R. Diaz, A. Robson, Y. Kotelevtsev, and J. Mullins, The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development, Endocrinology, vol.137, pp.794-797, 1996.

A. Thompson, V. Han, and K. Yang, Differential expression of 11??-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development, The Journal of Steroid Biochemistry and Molecular Biology, vol.88, issue.4-5, pp.367-375, 2004.
DOI : 10.1016/j.jsbmb.2003.12.014

J. Condon, M. Ricketts, C. Whorwood, and P. Stewart, Ontogeny and sexual dimorphic expression of mouse type 2 11??-hydroxysteroid dehydrogenase, Molecular and Cellular Endocrinology, vol.127, issue.2, pp.121-128, 1997.
DOI : 10.1016/S0303-7207(97)04000-8

J. Condon, C. Gosden, D. Gardener, P. Nickson, and M. Hewison, Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life, J Clin Endocrinol Metab, vol.83, pp.4490-4497, 1998.

L. Martinerie, S. Viengchareun, A. Delezoide, F. Jaubert, and M. Sinico, Low Renal Mineralocorticoid Receptor Expression at Birth Contributes to Partial Aldosterone Resistance in Neonates, Endocrinology, vol.150, issue.9, pp.4414-4424, 2009.
DOI : 10.1210/en.2008-1498
URL : https://hal.archives-ouvertes.fr/inserm-00385465

L. Martinerie, E. Pussard, L. Foix-l-'helias, F. Petit, and C. Cosson, Physiological Partial Aldosterone Resistance in Human Newborns, Pediatric Research, vol.164, issue.3, pp.323-328, 2009.
DOI : 10.1203/PDR.0b013e3181b1bbec
URL : https://hal.archives-ouvertes.fr/inserm-00383127

C. Lin, T. Wu, D. Machacek, N. Jiang, and P. Kao, Urinary Free Cortisol and Cortisone Determined by High Performance Liquid Chromatography in the Diagnosis of Cushing's Syndrome, Journal of Clinical Endocrinology & Metabolism, vol.82, issue.1, pp.151-155, 1997.
DOI : 10.1210/jc.82.1.151

R. Brown, K. Chapman, C. Edwards, and J. Seckl, Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform, Endocrinology, vol.132, pp.2614-2621, 1993.

B. Murphy, STEROID ARTERIOVENOUS DIFFERENCES IN UMBILICAL CORD PLASMA: EVIDENCE OF CORTISOL PRODUCTION BY THE HUMAN FETUS IN EARLY GESTATION, The Journal of Clinical Endocrinology & Metabolism, vol.36, issue.5, pp.1037-1038, 1973.
DOI : 10.1210/jcem-36-5-1037

T. Gwathmey, H. Shaltout, J. Rose, D. Diz, and M. Chappell, Glucocorticoid-Induced Fetal Programming Alters the Functional Complement of Angiotensin Receptor Subtypes Within the Kidney, Hypertension, vol.57, issue.3, pp.620-626, 2011.
DOI : 10.1161/HYPERTENSIONAHA.110.164970

H. Thony, C. Luethy, A. Zimmermann, R. Laux-end, and O. Oetliker, Histological features of glomerular immaturity in infants and small children with normal or altered tubular function, European Journal of Pediatrics, vol.60, issue.S4, pp.65-68, 1995.
DOI : 10.1007/BF02191509

H. Speirs, J. Seckl, and R. Brown, Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development, Journal of Endocrinology, vol.181, issue.1, pp.105-116, 2004.
DOI : 10.1677/joe.0.1810105

A. Atanasov, I. Ignatova, L. Nashev, B. Dick, and P. Ferrari, Impaired Protein Stability of 11beta-Hydroxysteroid Dehydrogenase Type 2: A Novel Mechanism of Apparent Mineralocorticoid Excess, Journal of the American Society of Nephrology, vol.18, issue.4, pp.1262-1270, 2007.
DOI : 10.1681/ASN.2006111235

S. Hundertmark, H. Buhler, M. Fromm, B. Kruner-gareis, and M. Kruner, Ontogeny of 11??-Hydroxysteroid Dehydrogenase: Activity in the Placenta, Kidney, Colon of Fetal Rats and Rabbits, Hormone and Metabolic Research, vol.33, issue.2, pp.78-83, 2001.
DOI : 10.1055/s-2001-12429

P. Stewart, F. Rogerson, and J. Mason, Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis, J Clin Endocrinol Metab, vol.80, pp.885-890, 1995.

J. Van-beek, H. Guan, L. Julan, and K. Yang, Glucocorticoids Stimulate the Expression of 11??-Hydroxysteroid Dehydrogenase Type 2 in Cultured Human Placental Trophoblast Cells, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.11, pp.5614-5621, 2004.
DOI : 10.1210/jc.2004-0113

S. Mesiano and R. Jaffe, Developmental and Functional Biology of the Primate Fetal Adrenal Cortex, Endocrine Reviews, vol.18, issue.3, pp.378-403, 1997.
DOI : 10.1210/er.18.3.378

N. Alfaidy, W. Li, T. Macintosh, K. Yang, and J. Challis, Late Gestation Increase in 11??-Hydroxysteroid Dehydrogenase 1 Expression in Human Fetal Membranes: A Novel Intrauterine Source of Cortisol, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.10, pp.5033-5038, 2003.
DOI : 10.1210/jc.2002-021915

J. Pasqualini, Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments, The Journal of Steroid Biochemistry and Molecular Biology, vol.97, issue.5, pp.401-415, 2005.
DOI : 10.1016/j.jsbmb.2005.08.004

N. Farman and B. Bocchi, Mineralocorticoid selectivity: Molecular and cellular aspects, Kidney International, vol.57, issue.4, pp.1364-1369, 2000.
DOI : 10.1046/j.1523-1755.2000.00976.x
URL : http://doi.org/10.1046/j.1523-1755.2000.00976.x

R. Diaz, R. Brown, and J. Seckl, Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions, J Neurosci, vol.18, pp.2570-2580, 1998.

M. Holmes, M. Sangra, K. French, I. Whittle, and J. Paterson, 11??-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids, Neuroscience, vol.137, issue.3, pp.865-873, 2006.
DOI : 10.1016/j.neuroscience.2005.09.037

S. Aucott, K. Watterberg, M. Shaffer, and P. Donohue, Do Cortisol Concentrations Predict Short-Term Outcomes in Extremely Low Birth Weight Infants?, PEDIATRICS, vol.122, issue.4, pp.775-781, 2008.
DOI : 10.1542/peds.2007-2252

K. Moritz, D. Matteo, R. Dodic, M. Jefferies, A. Arena et al., Prenatal glucocorticoid exposure in the sheep alters renal development in utero: implications for adult renal function and blood pressure control, AJP: Regulatory, Integrative and Comparative Physiology, vol.301, issue.2, pp.500-509, 2011.
DOI : 10.1152/ajpregu.00818.2010

L. Ortiz, A. Quan, A. Weinberg, and M. Baum, Effect of prenatal dexamethasone on rat renal development, Kidney International, vol.59, issue.5, pp.1663-1669, 2001.
DOI : 10.1046/j.1523-1755.2001.0590051663.x

L. Ortiz, A. Quan, F. Zarzar, A. Weinberg, and M. Baum, Prenatal Dexamethasone Programs Hypertension and Renal Injury in the Rat, Hypertension, vol.41, issue.2, pp.328-334, 2003.
DOI : 10.1161/01.HYP.0000049763.51269.51

M. Baum, Role of the kidney in the prenatal and early postnatal programming of hypertension, AJP: Renal Physiology, vol.298, issue.2, pp.235-247, 2011.
DOI : 10.1152/ajprenal.00288.2009